TBS-Based Preoperative Score to Predict Non-transplantable Recurrence and Identify Candidates for Upfront Resection Versus Transplantation for Hepatocellular Carcinoma.

MLA

Lima, Henrique A., et al. “TBS-Based Preoperative Score to Predict Non-Transplantable Recurrence and Identify Candidates for Upfront Resection Versus Transplantation for Hepatocellular Carcinoma.” Annals of Surgical Oncology, vol. 30, no. 6, June 2023, pp. 3363–73. EBSCOhost, https://doi.org/10.1245/s10434-023-13273-1.

APA

Lima, H. A., Moazzam, Z., Endo, Y., Alaimo, L., Shaikh, C., Munir, M. M., Resende, V., Guglielmi, A., Marques, H. P., Cauchy, F., Lam, V., Poultsides, G. A., Popescu, I., Alexandrescu, S., Martel, G., Hugh, T., Endo, I., Kitago, M., Shen, F., & Pawlik, T. M. (2023). TBS-Based Preoperative Score to Predict Non-transplantable Recurrence and Identify Candidates for Upfront Resection Versus Transplantation for Hepatocellular Carcinoma. Annals of Surgical Oncology, 30(6), 3363–3373. https://doi.org/10.1245/s10434-023-13273-1

Chicago

Lima, Henrique A, Zorays Moazzam, Yutaka Endo, Laura Alaimo, Chanza Shaikh, Muhammad Musaab Munir, Vivian Resende, et al. 2023. “TBS-Based Preoperative Score to Predict Non-Transplantable Recurrence and Identify Candidates for Upfront Resection Versus Transplantation for Hepatocellular Carcinoma.” Annals of Surgical Oncology 30 (6): 3363–73. doi:10.1245/s10434-023-13273-1.